#semaglutide — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #semaglutide, aggregated by home.social.
-
https://www.europesays.com/be-nl/70883/ Kan semaglutide helpen om te stoppen met roken? Misschien wel #BE #België #Belgium #Gezondheid #Health #ozempic #roken #semaglutide #Wegovy
-
Sahpra cracks down on illegal weight-loss drugs as GLP-1 demand booms
South Africa’s medicines regulator and pharmacy watchdog hav…
#NewsBeep #News #Medication #AU #Australia #BoitumeloSemete-Makokotlela. #GLP-1medicines #Health #iDexisCompounding #medicine #Medicines&RelatedSubstancesAct #pharmacovigilance #sahpra #SAPC #semaglutide #SentraPharmacy #SouthAfricanHealthProductsRegulatoryAuthority #SouthAfricanPharmacyCouncil #therapy #Tirzepatide #VincentTlala
https://www.newsbeep.com/au/695169/ -
Sahpra cracks down on illegal weight-loss drugs as GLP-1 demand booms
South Africa’s medicines regulator and pharmacy watchdog hav…
#NewsBeep #News #Medication #AU #Australia #BoitumeloSemete-Makokotlela. #GLP-1medicines #Health #iDexisCompounding #medicine #Medicines&RelatedSubstancesAct #pharmacovigilance #sahpra #SAPC #semaglutide #SentraPharmacy #SouthAfricanHealthProductsRegulatoryAuthority #SouthAfricanPharmacyCouncil #therapy #Tirzepatide #VincentTlala
https://www.newsbeep.com/au/695169/ -
https://www.europesays.com/ie/502941/ Sahpra cracks down on illegal weight-loss drugs as GLP-1 demand booms #BoitumeloSemeteMakokotlela #Éire #GLP1Medicines #Health #IDexisCompounding #IE #Ireland #Medication #medicine #Medicines&RelatedSubstancesAct #pharmacovigilance #sahpra #SAPC #semaglutide #SentraPharmacy #SouthAfricanHealthProductsRegulatoryAuthority #SouthAfricanPharmacyCouncil #therapy #tirzepatide #VincentTlala
-
Sahpra cracks down on illegal weight-loss drugs as GLP-1 demand booms
South Africa’s medicines regulator and pharmacy watchdog have i…
#NewsBeep #News #Medication #BoitumeloSemete-Makokotlela. #CA #Canada #GLP-1medicines #Health #iDexisCompounding #medicine #Medicines&RelatedSubstancesAct #pharmacovigilance #sahpra #SAPC #Semaglutide #SentraPharmacy #SouthAfricanHealthProductsRegulatoryAuthority #SouthAfricanPharmacyCouncil #therapy #tirzepatide #VincentTlala
https://www.newsbeep.com/ca/693714/ -
Sahpra cracks down on illegal weight-loss drugs as GLP-1 demand booms
South Africa’s medicines regulator and pharmacy watchdog …
#NewsBeep #News #Medication #boitumelosemete-makokotlela #GLP-1medicines #Health #iDexisCompounding #medicine #Medicines&RelatedSubstancesAct #pharmacovigilance #sahpra #SAPC #Semaglutide #sentrapharmacy #SouthAfricanHealthProductsRegulatoryAuthority #southafricanpharmacycouncil #Therapy #Tirzepatide #UK #UnitedKingdom #vincenttlala
https://www.newsbeep.com/uk/603726/ -
Sahpra cracks down on illegal weight-loss drugs as GLP-1 demand booms
South Africa’s medicines regu…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #BoitumeloSemete-Makokotlela. #GLP-1medicines #Health #iDexisCompounding #medicine #Medicines&RelatedSubstancesAct #pharmacovigilance #SAHPRA #SAPC #Semaglutide #SentraPharmacy #SouthAfricanHealthProductsRegulatoryAuthority #SouthAfricanPharmacyCouncil #Therapy #tirzepatide #VincentTlala
https://www.newsbeep.com/us/664883/ -
Sahpra cracks down on illegal weight-loss drugs as GLP-1 demand booms
South Africa’s medicines regu…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #BoitumeloSemete-Makokotlela. #GLP-1medicines #Health #iDexisCompounding #medicine #Medicines&RelatedSubstancesAct #pharmacovigilance #SAHPRA #SAPC #Semaglutide #SentraPharmacy #SouthAfricanHealthProductsRegulatoryAuthority #SouthAfricanPharmacyCouncil #Therapy #tirzepatide #VincentTlala
https://www.newsbeep.com/us/664883/ -
DATE: May 25, 2026 at 09:39AM
SOURCE: SCIENCE DAILY MIND-BRAIN FEEDTITLE: Scientists discover why Ozempic and Wegovy weight loss eventually plateaus
URL: https://www.sciencedaily.com/releases/2026/05/260525000453.htm
New NIH research reveals that semaglutide sparks different responses inside appetite-controlling brain cells, offering fresh insight into why GLP-1 weight-loss drugs don’t work the same for everyone. Scientists also found a possible way to extend the drugs’ effects, potentially helping patients push past weight-loss plateaus.
URL: https://www.sciencedaily.com/releases/2026/05/260525000453.htm
-------------------------------------------------
DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: http://subscribe-article-digests.clinicians-exchange.org
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
It's primitive... but it works... mostly...
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #Ozempic #Wegovy #Semaglutide #WeightLossPlateau #GLP1 #AppetiteControl #NIHResearch #WeightLossScience #DrugDevelopment #HealthNews
-
DATE: May 25, 2026 at 09:39AM
SOURCE: SCIENCE DAILY MIND-BRAIN FEEDTITLE: Scientists discover why Ozempic and Wegovy weight loss eventually plateaus
URL: https://www.sciencedaily.com/releases/2026/05/260525000453.htm
New NIH research reveals that semaglutide sparks different responses inside appetite-controlling brain cells, offering fresh insight into why GLP-1 weight-loss drugs don’t work the same for everyone. Scientists also found a possible way to extend the drugs’ effects, potentially helping patients push past weight-loss plateaus.
URL: https://www.sciencedaily.com/releases/2026/05/260525000453.htm
-------------------------------------------------
DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: http://subscribe-article-digests.clinicians-exchange.org
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
It's primitive... but it works... mostly...
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #Ozempic #Wegovy #Semaglutide #WeightLossPlateau #GLP1 #AppetiteControl #NIHResearch #WeightLossScience #DrugDevelopment #HealthNews
-
DATE: May 25, 2026 at 09:39AM
SOURCE: SCIENCE DAILY MIND-BRAIN FEEDTITLE: Scientists discover why Ozempic and Wegovy weight loss eventually plateaus
URL: https://www.sciencedaily.com/releases/2026/05/260525000453.htm
New NIH research reveals that semaglutide sparks different responses inside appetite-controlling brain cells, offering fresh insight into why GLP-1 weight-loss drugs don’t work the same for everyone. Scientists also found a possible way to extend the drugs’ effects, potentially helping patients push past weight-loss plateaus.
URL: https://www.sciencedaily.com/releases/2026/05/260525000453.htm
-------------------------------------------------
DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: http://subscribe-article-digests.clinicians-exchange.org
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
It's primitive... but it works... mostly...
-------------------------------------------------
#psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #Ozempic #Wegovy #Semaglutide #WeightLossPlateau #GLP1 #AppetiteControl #NIHResearch #WeightLossScience #DrugDevelopment #HealthNews
-
https://www.europesays.com/dk/91600/ Novo Nordisk Secures Dual EU Backing for Wegovy as Semaglutide Liver Data Strengthens Pipeline #Backing #data #dual #liver #Nordisk #novo #NovoNordisk #Secures #semaglutide #strengthens #Wegovy
-
Generic semaglutide to hit Canadian pharmacies this week at lower cost
Two generic versions of Ozempic and Wegovy are set to start arriving in Canadian pharmacies this week, which…
#NewsBeep #News #Medication #Consumer #GLP-1 #Health #Ozempic #Semaglutide #UK #UnitedKingdom #Wegovy #weight-lossdrugs
https://www.newsbeep.com/uk/602216/ -
https://www.europesays.com/dk/91040/ Novo Nordisk to unveil data showing semaglutide tackles the liver disease crisis affecting about 1 in 3 people living with overweight and obesity worldwide #EASL #JacobMartin #LiverCancer #LiverDisease #LiverFailure #LiverInflammation #LiverTransplantation #MASH #NovoNordisk #semaglutide #Steatohepatitis
-
https://www.europesays.com/dk/90414/ Novo Nordisk A/S: Wegovy® pill (oral semaglutide) recommended by CHMP for approval in the EU as the first oral GLP-1 representing the most efficacious oral obesity treatment in its class #A/S #Approval #as #by #CHMP #Class #efficacious #EU #First #for #GLP1 #in #Its #most #Nordisk #novo #NovoNordisk #Obesity #Oral #pill #Recommended #representing #semaglutide #the #Treatment #Wegovy
-
How GLP-1s are more than just weight-loss wonders – but not without risk
Not long ago, nobody was talking about GLP-1 receptor agonists. Most of us d…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #benefits #BodyBanter #Denmark #DrIvanChow #DrStephanieNg #DrWillChanYap-hang #fattyliverdisease #FDA #GLP-1receptoragonists #Health #hongkong #MASH #NovoNordisk #Ozempic #ProfessorLoeyMakLung-yi #Semaglutide #UniversityofHongKong #wegovy
https://www.newsbeep.com/us/659877/ -
How GLP-1s are more than just weight-loss wonders – but not without risk
Not long ago, nobody was talking about GLP-1 receptor agonists. Most of us d…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #benefits #BodyBanter #Denmark #DrIvanChow #DrStephanieNg #DrWillChanYap-hang #fattyliverdisease #FDA #GLP-1receptoragonists #Health #hongkong #MASH #NovoNordisk #Ozempic #ProfessorLoeyMakLung-yi #Semaglutide #UniversityofHongKong #wegovy
https://www.newsbeep.com/us/659877/ -
https://www.europesays.com/ie/498586/ How GLP-1s are more than just weight-loss wonders – but not without risk #Benefits #BodyBanter #Denmark #DrIvanChow #DrStephanieNg #DrWillChanYapHang #Éire #FattyLiverDisease #fda #GLP1ReceptorAgonists #Health #HongKong #IE #Ireland #MASH #Medication #NovoNordisk #ozempic #ProfessorLoeyMakLungYi #semaglutide #UniversityOfHongKong #Wegovy
-
https://www.europesays.com/dk/88341/ Novo Nordisk launches higher-dose Wegovy for those seeking greater weightloss #NovoNordisk #semaglutide #Wegovy
-
https://www.europesays.com/dk/88099/ Novo Nordisk to unveil data showing semaglutide tackles the liver disease crisis affecting about 1 in 3 people living with overweight and obesity worldwide #EASL #JacobMartin #LiverCancer #LiverDisease #LiverFailure #LiverInflammation #LiverTransplantation #MASH #NovoNordisk #semaglutide #Steatohepatitis
-
Generic semaglutide to hit Canadian pharmacies this week at lower cost
https://fed.brid.gy/r/https://globalnews.ca/news/11857122/generic-semaglutide-canada-sales-begin/
-
https://www.europesays.com/dk/87285/ Novo Nordisk Presses Forward With Oral Semaglutide and Amycretin as CagriSema Nears FDA Verdict #Amycretin #cagrisema #Forward #nears #Nordisk #novo #NovoNordisk #Oral #Presses #semaglutide #with
-
https://www.europesays.com/uk/973206/ GLP-1 drugs cut sick days, could save healthcare systems billions #AntiObesityDrugs #GLP1Drugs #Health #Medication #Ozempic #Semaglutide #UK #UnitedKingdom #Wegovy
-
https://www.europesays.com/dk/86120/ Novo Nordisk to unveil data showing semaglutide tackles the liver disease crisis affecting about 1 in 3 people living with overweight and obesity worldwide #EASL #JacobMartin #LiverCancer #LiverDisease #LiverFailure #LiverInflammation #LiverTransplantation #MASH #NovoNordisk #semaglutide #Steatohepatitis
-
GLP-1 drugs cut sick days, could save healthcare systems billions
New Delhi: Ozempic and Wegovy, the drugs that have dominated global health headlines for their dramatic weight-loss effects,…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #Anti-obesitydrugs #glp-1drugs #Health #Ozempic #Semaglutide #wegovy
https://www.newsbeep.com/us/652330/ -
GLP-1 drugs cut sick days, could save healthcare systems billions
New Delhi: Ozempic and Wegovy, the drugs that have dominated global health headlines for their dramatic weight-loss effects,…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #Anti-obesitydrugs #glp-1drugs #Health #Ozempic #Semaglutide #wegovy
https://www.newsbeep.com/us/652330/ -
https://www.europesays.com/dk/86094/ Novo Nordisk to unveil data showing semaglutide tackles the liver disease crisis affecting about 1 in 3 people living with overweight and obesity worldwide #1 #3 #About #affecting #and #Crisis #data #Disease #in #liver #living #Nordisk #novo #NovoNordisk #Obesity #overweight #people #semaglutide #Showing #tackles #the #to #unveil #with #worldwide
-
https://www.europesays.com/ie/492308/ GLP-1 drugs cut sick days, could save healthcare systems billions #AntiObesityDrugs #Éire #GLP1Drugs #Health #IE #Ireland #Medication #ozempic #semaglutide #Wegovy
-
Semaglutide Vs Tirzepatide Dosing: Why Yours Is Flawed
New research shows a 10‑mg weekly tirzepatide dose can cut BMI by up to 23% in MC4R‑deficient patients, eclipsing the 18% loss with the standard semaglutide regimen. Find out why current dosing may be holding patients back.
https://weightlossfacts.online/semaglutide-vs-tirzepatide-dosing-why-yours-is-fla/
#semaglutide #tirzepatide #dosingstrategy #mc4rdeficiency #bmiloss
-
Semaglutide Vs Tirzepatide Dosing: Why Yours Is Flawed
New research shows a 10‑mg weekly tirzepatide dose can cut BMI by up to 23% in MC4R‑deficient patients, eclipsing the 18% loss with the standard semaglutide regimen. Find out why current dosing may be holding patients back.
https://weightlossfacts.online/semaglutide-vs-tirzepatide-dosing-why-yours-is-fla/
#semaglutide #tirzepatide #dosingstrategy #mc4rdeficiency #bmiloss
-
🚨 @[email protected] is opening a new prequalification pathway for generic #semaglutide and rapid-acting #insulin analogues — a move aimed at expanding access to #diabetes care where treatment remains out of reach for many. @[email protected] 📖⬇️ & 🔁🙏
WHO Moves To Expand Access To ... -
🚨 @[email protected] is opening a new prequalification pathway for generic #semaglutide and rapid-acting #insulin analogues — a move aimed at expanding access to #diabetes care where treatment remains out of reach for many. @[email protected] 📖⬇️ & 🔁🙏
WHO Moves To Expand Access To ... -
🚨 @[email protected] is opening a new prequalification pathway for generic #semaglutide and rapid-acting #insulin analogues — a move aimed at expanding access to #diabetes care where treatment remains out of reach for many. @[email protected] 📖⬇️ & 🔁🙏
WHO Moves To Expand Access To ... -
🚨 @[email protected] is opening a new prequalification pathway for generic #semaglutide and rapid-acting #insulin analogues — a move aimed at expanding access to #diabetes care where treatment remains out of reach for many. @[email protected] 📖⬇️ & 🔁🙏
WHO Moves To Expand Access To ... -
https://www.europesays.com/at/162589/ GLP-1-Wirkstoffe verändern den Kampf gegen Adipositas – Nutzen, Kosten und nächste Innovationen #Adipositas #AT #Austria #erstattung #Gesundheit #GLP1 #Health #KlinischeStudie #Kosten #Mounjaro #Nebenwirkungen #NHS #NICE #Österreich #Prävention #Regulierung #Semaglutide #Tabletten #Tirzepatide #Wegovy
-
https://www.europesays.com/dk/82783/ Wegovy® delivered substantial weight loss in women across all menopause stages, plus heart and migraine protection, shown in new Novo Nordisk data at the European Congress on Obesity #BodyWeight #CardiovascularDisease #HeartAttacks #MenopausalHormoneTherapy #NovoNordisk #Obesity #premenopausal #semaglutide #WaistCircumference #WeightLoss #WeightManagement
-
https://www.europesays.com/dk/81267/ Wegovy® delivered substantial weight loss in women across all menopause stages, plus heart and migraine protection, shown in new Novo Nordisk data at the European Congress on Obesity #BodyWeight #CardiovascularDisease #HeartAttacks #MenopausalHormoneTherapy #NovoNordisk #Obesity #premenopausal #semaglutide #WaistCircumference #WeightLoss #WeightManagement
-
GLP-1 plus therapy can reduce heavy drinking
May 12, 2026 At a Glance People with alcohol use disorder and obesity drank less when treated with…
#NewsBeep #News #Medication #alcoholconsumption #alcoholusedisorder #AndersFink-Jensen #AU #aud #Australia #CBT #cognitivebehavioraltherapy #GLP-1receptoragonists #Health #Obesity #randomizedcontrolledtrial #RCT #semaglutide #thelancet
https://www.newsbeep.com/au/666447/ -
GLP-1 plus therapy can reduce heavy drinking
May 12, 2026 At a Glance People with alcohol use disorder and obesity drank less when treated with…
#NewsBeep #News #Medication #alcoholconsumption #alcoholusedisorder #AndersFink-Jensen #AU #aud #Australia #CBT #cognitivebehavioraltherapy #GLP-1receptoragonists #Health #Obesity #randomizedcontrolledtrial #RCT #semaglutide #thelancet
https://www.newsbeep.com/au/666447/ -
GLP-1 plus therapy can reduce heavy drinking
May 12, 2026 At a Glance People with alcohol use disorder and obesity drank less when treated with…
#NewsBeep #News #Medication #Alcoholconsumption #alcoholusedisorder #AndersFink-Jensen #aud #CA #Canada #CBT #cognitivebehavioraltherapy #GLP-1receptoragonists #Health #obesity #Randomizedcontrolledtrial #RCT #Semaglutide #TheLancet
https://www.newsbeep.com/ca/664846/ -
https://www.europesays.com/ie/481178/ GLP-1 plus therapy can reduce heavy drinking #AlcoholConsumption #AlcoholUseDisorder #AndersFinkJensen #aud #CBT #CognitiveBehavioralTherapy #Éire #GLP1ReceptorAgonists #Health #IE #Ireland #Medication #Obesity #RandomizedControlledTrial #RCT #semaglutide #TheLancet
-
https://www.europesays.com/uk/955141/ GLP-1 plus therapy can reduce heavy drinking #AlcoholConsumption #AlcoholUseDisorder #AndersFinkJensen #AUD #CBT #CognitiveBehavioralTherapy #GLP1ReceptorAgonists #Health #Medication #Obesity #RandomizedControlledTrial #RCT #Semaglutide #TheLancet #UK #UnitedKingdom
-
https://www.europesays.com/dk/80556/ Wegovy® delivered substantial weight loss in women across all menopause stages, plus heart and migraine protection, shown in new Novo Nordisk data at the European Congress on Obesity #BodyWeight #CardiovascularDisease #HeartAttacks #MenopausalHormoneTherapy #NovoNordisk #Obesity #premenopausal #semaglutide #WaistCircumference #WeightLoss #WeightManagement
-
https://www.europesays.com/dk/80449/ Higher dose Wegovy® demonstrates nearly 28% weight loss in early responders according to new analyses presented at the European Congress on Obesity #BodyWeight #eco #EuropeanCongressOnObesity #JacobMartin #NovoNordisk #semaglutide #WeightLoss
-
https://www.europesays.com/dk/80332/ Higher dose Wegovy® demonstrates nearly 28% weight loss in early responders according to new analyses presented at the European Congress on Obesity #BodyWeight #eco #EuropeanCongressOnObesity #JacobMartin #NovoNordisk #semaglutide #WeightLoss
-
https://www.europesays.com/dk/80320/ Higher dose Wegovy® demonstrates nearly 28% weight loss in early responders according to new analyses presented at the European Congress on Obesity #BodyWeight #eco #EuropeanCongressOnObesity #JacobMartin #NovoNordisk #semaglutide #WeightLoss
-
Novo Nordisk India Sees Sales Surge Amidst Price Wars
Novo Nordisk India sales grew 40% as generic drugs entered the market. Find out how branded drugs like Ozempic are still selling well.
#NovoNordiskIndia, #OzempicSales, #WeightLossDrugs, #PharmaIndia, #Semaglutide
https://newsletter.tf/novo-nordisk-india-sales-up-40-percent-generics/
-
Novo Nordisk India saw its sales jump by 40%. This is a big increase even though cheaper generic drugs are now available.
#NovoNordiskIndia, #OzempicSales, #WeightLossDrugs, #PharmaIndia, #Semaglutide
https://newsletter.tf/novo-nordisk-india-sales-up-40-percent-generics/
